TNF and rheumatoid arthritis: Thus, the aim of this study was to evaluate the usefulness of the quantitative serum assessment of individual markers of bone turnover as indicators of the clinical efficacy of anti-TNF-α therapy with etanercept and adalimumab in women with rheumatoid arthritis.